27 results
8-K
EX-1.1
RYTM
Rhythm Pharmaceuticals Inc.
15 Sep 22
Other Events
4:02pm
or cause to be paid all expenses incident to the performance of its obligations under this Agreement, including: (i) the fees, disbursements … with the review and qualification of the offering of the Shares by the Financial Industry Regulatory Authority, (v) all costs and expenses incident to listing
8-K
EX-1.1
RYTM
Rhythm Pharmaceuticals Inc.
5 Feb 21
Other Events
5:27pm
in this Agreement are consummated or this Agreement is terminated, to pay or cause to be paid all expenses incident to the performance of its … Industry Regulatory Authority, (v) all costs and expenses incident to listing the Shares on the Nasdaq Global Market, (vi) the cost of printing certificates
8-K
EX-3.1
RYTM
Rhythm Pharmaceuticals Inc.
11 Dec 20
Departure of Directors or Certain Officers
4:01pm
, the Chairperson shall have such powers and perform such duties that are commonly incident to the position of chairperson of the board or as may be prescribed … perform all acts incident to the position of Treasurer, subject to the control of the Board of Directors. The Treasurer shall when requested, pursuant
8-K
EX-3.1
RYTM
Rhythm Pharmaceuticals Inc.
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
shall have such powers and perform such duties that are commonly incident to the position of chairperson of the board or as may be prescribed from … . The Treasurer shall perform all acts incident to the position of Treasurer, subject to the control of the Board of Directors. The Treasurer shall when
8-K
EX-1.1
37v635
16 Oct 19
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
5:27pm
S-3ASR
EX-1.2
n40w0sz lp
9 Nov 18
Automatic shelf registration
4:35pm
S-3
EX-1.2
x0whahe66
2 Nov 21
Shelf registration
5:21pm
8-K
EX-10.1
9l067kce98ixqnxf
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm